Literature DB >> 12100695

Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis.

Anne Marie McNeill1, Ronald J Barr.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12100695

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  12 in total

1.  Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis.

Authors:  Bruce L Riser; Narasimharao Bhagavathula; Patricia Perone; Kendra Garchow; Yiru Xu; Gary J Fisher; Feridoon Najmabadi; Durga Attili; James Varani
Journal:  J Cell Commun Signal       Date:  2012-05-31       Impact factor: 5.782

2.  Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent.

Authors:  Narasimharao Bhagavathula; Marissa DaSilva; Muhammad N Aslam; Michael K Dame; Roscoe L Warner; Yiru Xu; Gary J Fisher; Kent J Johnson; Richard Swartz; James Varani
Journal:  Invest Radiol       Date:  2009-08       Impact factor: 6.016

Review 3.  Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

4.  Stimulation of fibroblast proliferation by insoluble gadolinium salts.

Authors:  Katherine Bleavins; Patricia Perone; Madhav Naik; Muneeb Rehman; Muhammad N Aslam; Michael K Dame; Sasha Meshinchi; Narasimharao Bhagavathula; James Varani
Journal:  Biol Trace Elem Res       Date:  2011-09-01       Impact factor: 3.738

Review 5.  Nephrogenic systemic fibrosis: an update.

Authors:  Shawn E Cowper; Philip J Boyer
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

6.  Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agent.

Authors:  Patricia A Perone; Stephanie L Weber; Marissa DaSilva; Tejaswi Paruchuri; Narasimharao Bhagavathula; Muhammad N Aslam; Michael K Dame; Kent J Johnson; Richard D Swartz; James Varani
Journal:  Invest Radiol       Date:  2010-01       Impact factor: 6.016

7.  Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer.

Authors:  Bruce L Riser; Jeffrey L Barnes; James Varani
Journal:  J Cell Commun Signal       Date:  2015-12-23       Impact factor: 5.782

Review 8.  Nephrogenic systemic fibrosis: an emerging entity.

Authors:  Sandip K Saxena; Manjuri Sharma; Mital Patel; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-17       Impact factor: 2.370

9.  Nephrogenic fibrosing dermopathy in pediatric patients.

Authors:  Sima M Jain; Stanton Wesson; Ashraf Hassanein; Erica Canova; Miranda Hoy; Robert S Fennell; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2004-02-10       Impact factor: 3.714

Review 10.  Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.

Authors:  Fabian A Mendoza; Carol M Artlett; Nora Sandorfi; Kevin Latinis; Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Semin Arthritis Rheum       Date:  2006-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.